ID   MK07_RAT                Reviewed;         806 AA.
AC   P0C865;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   02-SEP-2008, sequence version 1.
DT   02-OCT-2024, entry version 84.
DE   RecName: Full=Mitogen-activated protein kinase 7;
DE            Short=MAP kinase 7;
DE            Short=MAPK 7;
DE            EC=2.7.11.24;
DE   AltName: Full=Big MAP kinase 1;
DE            Short=BMK-1;
DE   AltName: Full=Extracellular signal-regulated kinase 5;
DE            Short=ERK-5;
GN   Name=Mapk7; Synonyms=Bmk1, Erk5;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   FUNCTION, AND INTERACTION WITH MEF2A; MEF2C AND MEF2D.
RX   PubMed=9753748; DOI=10.1093/nar/26.20.4771;
RA   Yang C.-C., Ornatsky O.I., McDermott J.C., Cruz T.F., Prody C.A.;
RT   "Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated
RT   protein kinase, ERK5/BMK1.";
RL   Nucleic Acids Res. 26:4771-4777(1998).
RN   [3]
RP   FUNCTION.
RX   PubMed=20724525; DOI=10.1096/fj.10-162636;
RA   Woo C.H., Le N.T., Shishido T., Chang E., Lee H., Heo K.S., Mickelsen D.M.,
RA   Lu Y., McClain C., Spangenberg T., Yan C., Molina C.A., Yang J.,
RA   Patterson C., Abe J.;
RT   "Novel role of C terminus of Hsc70-interacting protein (CHIP) ubiquitin
RT   ligase on inhibiting cardiac apoptosis and dysfunction via regulating ERK5-
RT   mediated degradation of inducible cAMP early repressor.";
RL   FASEB J. 24:4917-4928(2010).
RN   [4]
RP   INTERACTION WITH HSP90AB1.
RX   PubMed=23428871; DOI=10.1128/mcb.01246-12;
RA   Erazo T., Moreno A., Ruiz-Babot G., Rodriguez-Asiain A., Morrice N.A.,
RA   Espadamala J., Bayascas J.R., Gomez N., Lizcano J.M.;
RT   "Canonical and kinase activity-independent mechanisms for extracellular
RT   signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation
RT   of Hsp90 from the ERK5-Cdc37 complex.";
RL   Mol. Cell. Biol. 33:1671-1686(2013).
CC   -!- FUNCTION: Plays a role in various cellular processes such as
CC       proliferation, differentiation and cell survival. The upstream
CC       activator of MAPK7 is the MAPK kinase MAP2K5. Upon activation, it
CC       translocates to the nucleus and phosphorylates various downstream
CC       targets including MEF2C. EGF activates MAPK7 through a Ras-independent
CC       and MAP2K5-dependent pathway. As part of the MAPK/ERK signaling
CC       pathway, acts as a negative regulator of apoptosis in cardiomyocytes
CC       via interaction with STUB1/CHIP and promotion of STUB1-mediated
CC       ubiquitination and degradation of ICER-type isoforms of CREM
CC       (PubMed:20724525). May have a role in muscle cell differentiation. May
CC       be important for endothelial function and maintenance of blood vessel
CC       integrity. MAP2K5 and MAPK7 interact specifically with one another and
CC       not with MEK1/ERK1 or MEK2/ERK2 pathways. Phosphorylates SGK1 at Ser-78
CC       and this is required for growth factor-induced cell cycle progression
CC       (By similarity). Involved in the regulation of p53/TP53 by disrupting
CC       the PML-MDM2 interaction (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:20724525, ECO:0000269|PubMed:9753748}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.24;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.24;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ACTIVITY REGULATION: Activated by tyrosine and threonine
CC       phosphorylation. Activated in response to hyperosmolarity, hydrogen
CC       peroxide, and epidermal growth factor (EGF) (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with MAP2K5. Forms oligomers (By similarity).
CC       Interacts with MEF2A, MEF2C and MEF2D; the interaction phosphorylates
CC       the MEF2s and enhances transcriptional activity of MEF2A, MEF2C but not
CC       MEF2D. Interacts with SGK1 (By similarity). Interacts with PML (By
CC       similarity). Interacts (via N-terminal half) with HSP90AB1-CDC37
CC       chaperone complex in resting cells; the interaction is MAP2K5-
CC       independent and prevents MAPK7 from ubiquitination and proteasomal
CC       degradation (PubMed:23428871). Interacts with STUB1/CHIP; the
CC       interaction is enhanced in the presence of IGF1 or MAP2K5 and promotes
CC       STUB1/CHIP E3 ligase activity (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q13164, ECO:0000269|PubMed:23428871}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Nucleus, PML body
CC       {ECO:0000250}. Note=Translocates to the nucleus upon activation.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The second proline-rich region may interact with actin
CC       targeting the kinase to a specific location in the cell.
CC   -!- DOMAIN: The TXY motif contains the threonine and tyrosine residues
CC       whose phosphorylation activates the MAP kinases.
CC   -!- PTM: Dually phosphorylated on Thr-219 and Tyr-221, which activates the
CC       enzyme. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. MAP kinase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR03073216; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   AlphaFoldDB; P0C865; -.
DR   SMR; P0C865; -.
DR   STRING; 10116.ENSRNOP00000054673; -.
DR   iPTMnet; P0C865; -.
DR   PhosphoSitePlus; P0C865; -.
DR   jPOST; P0C865; -.
DR   PaxDb; 10116-ENSRNOP00000054673; -.
DR   UCSC; RGD:621505; rat.
DR   AGR; RGD:621505; -.
DR   RGD; 621505; Mapk7.
DR   eggNOG; KOG0660; Eukaryota.
DR   InParanoid; P0C865; -.
DR   PhylomeDB; P0C865; -.
DR   Reactome; R-RNO-198753; ERK/MAPK targets.
DR   Reactome; R-RNO-198765; Signalling to ERK5.
DR   Reactome; R-RNO-202670; ERKs are inactivated.
DR   Reactome; R-RNO-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-RNO-881907; Gastrin-CREB signalling pathway via PKC and MAPK.
DR   Reactome; R-RNO-8853659; RET signaling.
DR   PRO; PR:P0C865; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0016605; C:PML body; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0004707; F:MAP kinase activity; IDA:RGD.
DR   GO; GO:0051019; F:mitogen-activated protein kinase binding; ISO:RGD.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0033173; P:calcineurin-NFAT signaling cascade; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; ISO:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; ISO:RGD.
DR   GO; GO:0071499; P:cellular response to laminar fluid shear stress; ISO:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; ISO:RGD.
DR   GO; GO:0070375; P:ERK5 cascade; IMP:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0000165; P:MAPK cascade; IMP:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0070885; P:negative regulation of calcineurin-NFAT signaling cascade; ISO:RGD.
DR   GO; GO:2000352; P:negative regulation of endothelial cell apoptotic process; ISO:RGD.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; ISO:RGD.
DR   GO; GO:0034115; P:negative regulation of heterotypic cell-cell adhesion; ISO:RGD.
DR   GO; GO:1902176; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0060761; P:negative regulation of response to cytokine stimulus; ISO:RGD.
DR   GO; GO:0034392; P:negative regulation of smooth muscle cell apoptotic process; IMP:UniProtKB.
DR   GO; GO:0051247; P:positive regulation of protein metabolic process; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0045765; P:regulation of angiogenesis; ISO:RGD.
DR   CDD; cd07855; STKc_ERK5; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR050117; MAP_kinase.
DR   InterPro; IPR003527; MAP_kinase_CS.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24055; MITOGEN-ACTIVATED PROTEIN KINASE; 1.
DR   PANTHER; PTHR24055:SF588; MITOGEN-ACTIVATED PROTEIN KINASE 7; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS01351; MAPK; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cell cycle; Cytoplasm; Differentiation; Kinase;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q13164"
FT   CHAIN           2..806
FT                   /note="Mitogen-activated protein kinase 7"
FT                   /id="PRO_0000349105"
FT   DOMAIN          55..347
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2..77
FT                   /note="Required for cytoplasmic targeting"
FT                   /evidence="ECO:0000250"
FT   REGION          78..139
FT                   /note="Required for binding to MAP2K5"
FT                   /evidence="ECO:0000250"
FT   REGION          140..406
FT                   /note="Necessary for oligomerization"
FT                   /evidence="ECO:0000250"
FT   REGION          407..806
FT                   /note="May not be required for kinase activity; required to
FT                   stimulate MEF2C activity"
FT                   /evidence="ECO:0000250"
FT   REGION          424..475
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          488..727
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           219..221
FT                   /note="TXY"
FT                   /evidence="ECO:0000250"
FT   MOTIF           505..539
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        1..18
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        506..545
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        578..600
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        601..615
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        622..644
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        645..663
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        675..691
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        692..712
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        182
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         61..69
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         84
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13164"
FT   MOD_RES         710
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13164"
FT   MOD_RES         723
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13164"
SQ   SEQUENCE   806 AA;  87827 MW;  3CF236450A348C82 CRC64;
     MAEPLKEEDG EDGSGEPPGR VKAEPVHTAA SVVAKNLALL KARSFDVTFD VGDEYEIIET
     IGNGAYGVVS SARRRLTGQQ VAIKKIPNAF DVVTNAKRTL RELKILKHFK HDNIIAIKDI
     LRPTVPYGEF RSVYVVLDLM ESDLHQIIHS SQPLTLEHVR YFLYQLLRGL KYMHSAQVIH
     RDLKPSNLLV NENCELKIGD FGMARGLCTS PAEHQYFMTE YVATRWYRAP ELMLSLHEYT
     QAIDLWSVGC IFGEMLARRQ LFPGKNYVHQ LQLIMMVLGT PSPAVIQAVG AERVRAYIQS
     LPPRQPVPWE TVYPGADRQA LSLLGRMLRF EPSARISAAA ALRHPFLAKY HDPDDEPDCA
     PPFDFAFDRE ALTRERIKEA IVAEIEDFHA RREGIRQQIR FQPSLQPVAS EPVCPDVEMP
     SPWAPSGDCA MESPPPALPP CSGPAPDTVD LTLQPAPPAS ELAPPKREGA ISDNTKAALK
     AALLKSLRSR LRDGPSAPLE APEPRKPVTA QERQREREEK RRRRQERAKE REKRRQERER
     KERGAGTLGG PSTDPLAGLV LSDNDRSLLE RWTRMARPPV PAPAPAPAPT PKPSSAQPTS
     PPNGPVSQST APLQPAGSIP GPASQPVCPP PGPVPQPAGP VPAPLQTAPS TSLLASQSLV
     PPSGLPGSGA PEVLPYFPSG PPPPDPGLTP QPSTSESPDV NLVTQQLSKS QVEDPLPPVF
     SGTPKGSGAG YGVGFDLEEF LNQSFDMGVA DGPQDGQADS ASLSASLLAD WLEGHGMNPA
     DIESLQREIQ MDSPMLLSDL PDLQEP
//
